ArticlePloS one2023
A survey of UK beekeeper's Varroa treatment habits.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Article
- Monitoring Free-Living Honeybee Colonies in Germany: Insights Into Habitat Preferences, Survival Rates, and Citizen Science Reliability.Ecology and evolution · 2025Article
- Article
- Recapping and mite removal behaviour in Cuba: home to the world's largest population of Varroa-resistant European honeybees.Scientific reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global spread of the parasitic mite Varroa destructor instigated a substantial decline in both managed and feral honeybee (Apis mellifera) colonies mainly across the Northern hemisphere. In response, many beekeepers began to treat their colonies with chemical acaricides to control mite populations in managed colonies. However, some countries or beekeepers allowed their bees to develop mite-resistance by adopting a "treatment-free" approach, rather than using selective breeding programs. Yet, the distribution and proportion of beekeepers either treating or not within the United Kingdom (UK) is unknown, as it is in most Northern hemisphere countries. Therefore, the aim of this study was to conduct a beekeeper survey to determine the current treatment strategies within the UK. We gathered 2,872 beekeeper responses from an estimated 30,000 UK beekeepers belonging to 242 bee-associations in the winter of 2020/21. The survey indicated that the majority (72-79%) of UK beekeepers are still treating their bees for Varroa, typically twice-yearly using chemical-based methods. Six percent or 1,800 UK beekeepers were treatment-free for six years or more. This is reflected by our finding that 78 associations out of 242 consist of responders who entirely treated, while only four associations had more than 75% of their members that were non-treating. Overall treatment status was not affected by association currently. Using the baseline data from this survey it will be possible in the future to observer if a shift towards treatment-free beekeeping occurs or not.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.